Battlefield Pain Management – Analgesic
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency Contracting Activity (DHACA) intends to issue a Request for Prototype Proposal (RPP) for Battlefield Pain Management – Analgesic. This presolicitation seeks the development of an analgesic product with moderate to severe pain indication, aiming for FDA approval for battlefield use. The RPP is expected in Q3-Q4, Fiscal Year 2026.
Scope of Work
This RPP will focus on the development of an analgesic product, including combination products, for use at the point of injury during Tactical Combat Casualty Care and/or Prolonged Casualty Care. The goal is to achieve Food and Drug Administration (FDA) approval. The intent is to maximize competition and innovation by being open to any analgesic product.
Contract & Timeline
- Type: Presolicitation for a future Request for Prototype Proposal (RPP)
- Contracting Office: Defense Health Agency Contracting Activity (DHACA), Research & Development Contracting Division 2
- Product Service Code: AN13 (Health R&D Services; Health Care Services; Experimental Development)
- Set-Aside: None specified
- RPP Publication Expectation: Quarter 3 – Quarter 4, Fiscal Year 2026
- Awards Expectation: Up to two awards, Quarter 1 – Quarter 2, Fiscal Year 2027
- Presolicitation Notice End Date: May 29, 2026
- Published Date: April 23, 2026
Additional Notes
This is a presolicitation notice. Multiple awards may be made, subject to funding and evolving Government requirements. An Emergency Use Authorization (EUA) is a potential strategy for early delivery to Warfighters. No telephone calls will be accepted regarding this notice.
Primary Contact: Shannon Lertora (shannon.p.lertora.civ@health.mil)